Your browser doesn't support javascript.
loading
Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death.
Hwang, Sewon; Park, Soojun; Kim, Jee Hyun; Bang, Sang-Beom; Kim, Hyeon-Ji; Ka, Na-Lee; Ko, Yoonae; Kim, Seung-Su; Lim, Ga Young; Lee, Seunghee; Shin, Young Kee; Park, So Yeon; Kim, Sanghee; Lee, Mi-Ock.
Afiliação
  • Hwang S; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Park S; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Kim JH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi, Republic of Korea.
  • Bang SB; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.
  • Kim HJ; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
  • Ka NL; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
  • Ko Y; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Kim SS; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Lim GY; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Lee S; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
  • Shin YK; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Scie
  • Park SY; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi, Republic of Korea. Electronic address: sypmd@snu.ac.kr.
  • Kim S; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: pennkim@snu.ac.kr.
  • Lee MO; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea; Bio-MAX institute, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: molee@snu.ac.kr.
Life Sci ; 328: 121827, 2023 Sep 01.
Article em En | MEDLINE | ID: mdl-37276910
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Life Sci Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Life Sci Ano de publicação: 2023 Tipo de documento: Article